KY HB248 | 2020 | Regular Session
Status
Spectrum: Slight Partisan Bill (Republican 4-2)
Status: Introduced on January 13 2020 - 25% progression, died in committee
Action: 2020-01-15 - to Health and Family Services (H)
Pending: House Health and Family Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 13 2020 - 25% progression, died in committee
Action: 2020-01-15 - to Health and Family Services (H)
Pending: House Health and Family Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Create various new sections of KRS Chapter 367 to define terms; to prohibit manufacturers and wholesalers of off-patent or generic prescription drugs from engaging in unrestricted price increases; to require the secretary of the Cabinet for Health and Family Services to report certain price increases to the Attorney General; to establish that certain price increases for off-patent or generic drugs constitute a violation of KRS 367.170; establish penalties.
Title
AN ACT relating to prescription drugs.
Sponsors
Rep. Danny Bentley [R] | Rep. Deanna Frazier Gordon [R] | Rep. Ed Massey [R] | Rep. Maria Sorolis [D] |
Rep. Russell Webber [R] | Rep. Susan Westrom [D] |
History
Date | Chamber | Action |
---|---|---|
2020-01-15 | House | to Health and Family Services (H) |
2020-01-13 | House | introduced in House |
Subjects
Kentucky State Sources
Type | Source |
---|---|
Summary | https://apps.legislature.ky.gov/record/20RS/hb248.html |
Text | https://apps.legislature.ky.gov/recorddocuments/bill/20RS/hb248/orig_bill.pdf |